4559:TYO
Zeria Pharmaceutical Co Ltd
¥2,008.00
0.00%
(0.00) 1D
Oct 19, 3:30:00 PM GMT+9 · JPY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4559...
Open
¥2,016
High
¥2,024
Low
¥2,004
Mkt. cap
100.64B
Avg. vol.
158.78K
Volume
160.40K
Dividend
2.44%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
10.75
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥187
Shares outstanding
50.11M
No. of employees
2K
Open
¥2,016
High
¥2,024
Low
¥2,004
Mkt. cap
100.64B
Avg. vol.
158.78K
Volume
160.40K
Dividend
2.44%
Quarterly dividend
¥12
Ex-dividend date
Sep 29, 2026
P/E ratio
10.75
52-wk high
¥2,434
52-wk low
¥1,878
EPS
¥187
Shares outstanding
50.11M
No. of employees
2K
News stories
From web sources and news partners
BigGo Finance
·
15 minutes ago
Dow Falls 36 Points for Second Straight Session as Oil Rally Weighs, AI-Related Buying Provides Support
Bloomberg
·
1 hour ago
US Stock Futures Edge Higher After Chipmaker Rally: Markets Wrap
TradingView
·
59 minutes ago
Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day Line
Investing.com
·
2 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
Profile
Zeria Shinyaku Kōgyō KK is a Japanese drug manufacturer that obtained Tillotts Pharma AG.
In 1955, the Japanese Kisaku Ibu, former Yamanouchi Seiyaku executive opened a new pharmaceutical company in Tokyo under the name Zeria Yakushō Kenkyusho. In 1970, this company becomes Zeria Shinyaku Zeria Shinyaku KK.
In 1975, it built a new factory in Kumagaya in Saitama prefecture, before the main factory in Tsukuba which was constructed by Takenaka Corporation in 1988.
In 2009, the company obtained Switzerland company Tillotts Pharma AG, and began operating internationally through a large network of subsidiaries,
It manufactures and sells pharmaceuticals in Sweden, Ireland, UK, Czech Republic, Spain, Germany, France, Italy, Vietnam and Denmark. The drug itself is developed in Switzerland, Tillotts Parma.
The company owns a 6.63% share of Asuka Seiyaku, also a pharmaceutical company, other than its subsidiaries.
The main shareholder of the company is the company itself, the present president Mitsuhiro Ibu, Mitsubishi UFJ Financial Group, Custody Bank of Japan, Morinaga Milk Industry, SMBC, Mizuho Bank, Risona Bank, Aioi Nissay Dowa Insurance as of March 2023. Wikipedia
About Zeria Pharmaceutical Co Ltd
CEOSachiaki Ibe
Employees1.75K
FoundedDec 22, 1955
Headquarters-
SectorPharmaceutical industry
Websitezeria.co.jp